Labcorp Holdings Inc. (LH)
| Market Cap | 22.09B |
| Revenue (ttm) | 13.48B |
| Net Income (ttm) | 763.40M |
| Shares Out | 83.10M |
| EPS (ttm) | 9.07 |
| PE Ratio | 29.32 |
| Forward PE | 15.80 |
| Dividend | $2.88 (1.08%) |
| Ex-Dividend Date | Aug 28, 2025 |
| Volume | 555,186 |
| Open | 259.82 |
| Previous Close | 259.96 |
| Day's Range | 259.52 - 266.79 |
| 52-Week Range | 209.38 - 283.47 |
| Beta | 0.76 |
| Analysts | Strong Buy |
| Price Target | 290.00 (+9.08%) |
| Earnings Date | Jul 24, 2025 |
About LH
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target... [Read more]
Financial Performance
In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.
Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for LH stock is "Strong Buy." The 12-month stock price target is $290.0, which is an increase of 9.08% from the latest price.
News
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
Test Finder interprets provider questions in context to deliver curated, clinically relevant results, going beyond traditional search Developed in collaboration with Amazon Web Services, Test Finder i...
Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU
First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for patients across the EU BURLINGTON, N.C. , July 29, 2025 /PRNewswire/ -- Lab...
These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings
Labcorp Holdings Inc. LH on Thursday reported stronger-than-expected results for the second quarter.
Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript
Labcorp Holdings Inc. (NYSE:LH) Q2 2025 Earnings Conference Call July 24, 2025 9:00 AM ET Company Participants Adam H. Schechter - President, CEO & Chairman Christin O'Donnell - Vice President of Inv...
Why Is Testing Giant Labcorp Stock Surging On Thursday?
Laboratory Corp (NYSE: LH) on Thursday reported second-quarter 2025 adjusted earnings per share of $4.35, up from $3.94 a year ago, beating the consensus of $4.17.
Labcorp raises annual profit forecast on strong diagnostic testing demand
Labcorp raised its annual profit forecast on Thursday after beating Wall Street estimates for second-quarter profit and revenue on robust demand for its diagnostic tests.
Labcorp Announces 2025 Second Quarter Results
Raises Full-Year Guidance Financial results from Operations for second quarter 2025 versus second quarter 2024: Revenue: $3.53 billion versus $3.22 billion Diluted EPS: $2.84 versus $2.43 Adjusted EPS...
Community Health Systems Announces Definitive Agreement to Sell Select Outreach Laboratory Assets to Labcorp
FRANKLIN, Tenn. & BURLINGTON, N.C.--(BUSINESS WIRE)--Community Health Systems, Inc. (Company) (NYSE: CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered int...
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C. , July 10, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has ...
Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low
In my follow-up article on Labcorp, I am upgrading it to a 'Buy' this time. Macro forecasts and the firm's own portfolio growth of solutions and locations could drive more tailwinds to the top line. L...
Labcorp to Announce Second Quarter Financial Results on July 24, 2025
BURLINGTON, N.C. , June 26, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the secon...
ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage
LOS ANGELES, June 02, 2025 (GLOBE NEWSWIRE) -- InStride , a leading provider of strategic education and skilling solutions, has facilitated a unique partnership between Arizona State University's Coll...
Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research
New test offerings target solid tumors and hematologic malignancies Enhanced biopharma services support accelerated clinical trials and companion diagnostic development BURLINGTON, N.C. , May 30, 2025...
Labcorp to Webcast Its Annual Meeting of Shareholders May 15
BURLINGTON, N.C., May 8, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be w...
Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript
Labcorp Holdings Inc. (NYSE:LH) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Company Participants Christin O'Donnell - Investor Relations Adam Schechter - Chairman & Chief Executive Off...
Labcorp beats quarterly profit estimate on diagnostic test demand
Laboratory operator Labcorp beat analysts' estimate for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.
Labcorp Announces 2025 First Quarter Results
Updates Full-Year Guidance Results from Operations for first quarter 2025 versus first quarter last year: Revenue: $3.35 billion versus $3.18 billion Diluted EPS: $2.52 versus $2.69 Adjusted EPS: $3.8...
Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions
Labcorp® Plasma Detect™ now available for clinical use to assess risk of recurrence in stage III colon cancer patients FDA-authorized liquid biopsy assay PGDx elio® plasma focus™ Dx now available to s...
Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics
Dublin, April 11, 2025 (GLOBE NEWSWIRE) -- The "Genetic Screening Testing for Preventive Health Market - A Global and Regional Analysis: Focus on Test Type, Technology, Application, End User and Count...
Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease
Labcorp's pTau-217/Beta Amyloid 42 Ratio blood test meets the performance criteria to confirm amyloid pathology consistent with Alzheimer's disease BURLINGTON, N.C. , April 2, 2025 /PRNewswire/ -- Lab...
Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide
New offering expands screening options for cervical cancer and sexually transmitted infections (STIs), including chlamydia, gonorrhea, trichomonas or mycoplasma genitalium (Mgen) BURLINGTON, N.C. , Ap...
Labcorp to Announce First Quarter Financial Results on April 29, 2025
BURLINGTON, N.C. , March 31, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the firs...
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Transaction to extend Labcorp's leadership in oncology and expand access to the company's high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI , March 11, 2025 /PRNewswire/ -- Labcorp ...
Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors
Labcorp® Plasma CompleteTM offers oncologists a highly sensitive and specific genomic profiling solution from a simple blood draw BURLINGTON, N.C. , Feb. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a...
Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold'
Labcorp Holdings Inc., a leader in life sciences and diagnostics, is efficiently managing its financials and focusing on core strengths for long-term growth, warranting a “Hold” rating. Competitive ad...